Replimune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. 

CEO
Sushil Patel
CEOSushil Patel
Employees
465
Employees465
Headquarters
Woburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded
2015
Founded2015
Employees
465
Employees465

REPL Key Statistics

Market cap
2.05B
Market cap2.05B
Price-Earnings ratio
-7.41
Price-Earnings ratio-7.41
Dividend yield
—
Dividend yield—
Average volume
4.53M
Average volume4.53M
High today
$21.91
High today$21.91
Low today
$19.91
Low today$19.91
Open price
$20.20
Open price$20.20
Volume
2.97M
Volume2.97M
52 Week high
$21.91
52 Week high$21.91
52 Week low
$1.50
52 Week low$1.50

Stock Snapshot

Replimune(REPL) stock is priced at $21.61, giving the company a market capitalization of 2.05B. It carries a P/E multiple of -7.41.

On 2026-11-06, Replimune(REPL) stock traded between a low of $19.91 and a high of $21.91. Shares are currently priced at $21.61, which is +8.5% above the low and -1.3% below the high.

Replimune(REPL) shares are trading with a volume of 2.97M, against a daily average of 4.53M.

During the past year, Replimune(REPL) stock moved between $1.50 at its lowest and $21.91 at its peak.

During the past year, Replimune(REPL) stock moved between $1.50 at its lowest and $21.91 at its peak.

REPL News

Investing.com 10h
Replimune Group stock hits 52-week high at 21.27 USD - Investing.com

...

Replimune Group stock hits 52-week high at 21.27 USD - Investing.com
Simply Wall St 12h
What Just Happened With Replimune Group?

Replimune Group (REPL) just reported second quarter and first half results, with net losses narrowing to US$57.12 million and US$126.89 million, compared with U...

What Just Happened With Replimune Group?
Simply Wall St 4d
Is Replimune Group Above Fair Value After A 119% Jump?

has seen its share price climb sharply in 2026, which puts a spotlight on a simple question for anyone looking at the stock today. Is the latest jump in Replimu...

Is Replimune Group Above Fair Value After A 119% Jump?

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.